Abstract
Cancer Biotherapy and Radiopharmaceuticals (CBR)
is officially retracting the published article by Jiapeng Xu, Weimin Wang, Zhenxin Zhu, Ziran Wei, Dejun Yang, and Qingping Cai entitled, “Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation In Vitro,” Cancer Biother Radiopharm June 2015, 30(3): 111–116; DOI: 10.1089/cbr.2014.1766
The editors of CBR received a letter from an investigator raising concerns regarding this published paper. The investigator claims that this study employed the 5′-GTAG… shRNA sequence as a “negative control”, despite the fact that according to Blastn analyses, this sequence shows homology to the human NOB1 gene. The investigator's concern is that since the article did not employ a non-targeting lentiviral construct as described in the study, it most likely invalidates the experimental results reported in the article. The authors of the article were afforded the opportunity to respond, and they disagreed with the concerns. However, the editors have decided to retract the article based on dispute and the serious nature of the plausibility of the raised concerns.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
